The pharmaceutical industry is comprised of multiple supply chains, due to its complexity. From an idea’s inception, to ...

Rising recalls, tighter FDA enforcement, global supply chain dependencies, and rapid technology shifts are reshaping pharmaceutical quality and compliance—forcing manufacturers to rethink oversight, ...

Under the deal, AbbVie agreed to lower prices on certain Medicaid drugs and expand distribution via the TrumpRx direct-to-patient platform.

Cambrex revealed plans spend $120 million to expand its Iowa manufacturing operations on the heels of a report last month that its owner was seeking a sale. The investment, which is part of the ...

The U.S. will impose a 100% tariff on "all any branded or patented Pharmaceutical Product" entering the country from Oct. 1. The measure will not apply to companies building drug manufacturing plants ...

PARK CITY, Utah & IRVINE, Calif.--(BUSINESS WIRE)--BioSelective Capital Investments and Shayan Enterprises, LLC, a Utah-based risk-capital investment firm, today announced the successful acquisition ...

— Investment More Than Doubles Capacity for Spray Drying, a Critical Solubility Enhancement Technology That Could Benefit the Development of 70% of Drugs* — EAST WINDSOR, N.J.--(BUSINESS ...

Amid an outpouring of industry investments in U.S. drug production, the FDA has launched a new program designed to significantly reduce the complexities involved in setting up domestic manufacturing ...

Eli Lilly announced plans on Tuesday to build a $5 billion drug manufacturing facility in Virginia. The announcement comes amid pressure from President Donald Trump to bring more drug manufacturing to ...

The "Cytotoxic Drugs & HPAPI Manufacturing Market Industry Trends and Global Forecasts to 2035, by Type of Product, Company Size, Scale of Operation, Type of Molecule, Type of Highly Potent Finished ...

Life sciences companies from around the globe continued to favor North Carolina for both new sites and expanded operations in ...